Both of these funds have made for good, market-beating investments over the past 10 years. But by focusing on the Nasdaq-100, which includes the top non-financial stocks on the exchange, the Invesco fund has been the far better investment during that stretch.

Growth stocks have been all the rage in the post-pandemic era, and there’s a good chance that they could continue spearheading the market’s gains. The current economic fundamentals look solid, and some believe it is almost too good to be true.

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.

There are some excellent opportunities for long-term investors as we head into 2025, and not just in beaten-down areas of the market like dividend stocks and real estate. In this video, Tyler Crowe and I discuss why these two growth stocks should be on your radar right now.